Circumstance such as high manufacturing complexities and costs, rigorous regulatory requirements in countries, and innovative strategies by biologic drug manufacturers to restrict the entry of new players are restraining the growth of this market.
Gain Latest Insights On:
Learn the current global regulatory guidelines and considerations for developing and bringing the next generation of Biosimilars to the market
Know the strategies in place in developing and manufacturing biosimilars in emerging markets
Emerging Markets: Challenges and Benefits in Investing in Emerging Markets
Establishing and integration of biosimilarity and comparability into developing Biosimilars
Identify challenges encountered with Extrapolations and interchangeability, assessing immunogenicity and Pharmacovigilance
Explore CMC regulatory challenges and considerations for Biosimilars drug development and manufacturing
Study the pre-clinical and clinical challenges associated with the development of biosimilars
The importance of establishing partnerships and successful collaboration for Biosimilars business
Learn the latest updates, trends and current Biosimilars market situations in different regions
What does the future hold for Biosimilars and Biologics
You will meet: Chief Executives, Executive Directors, Vice Presidents, Head Team Leaders and Manager
